Evidence for a New Crystalline Phase of Racemic Ibuprofen
- 966 Downloads
The aim of this work is to search for the existence of crystalline polymorphism for racemic Ibuprofen.
The pharmaceutical material was studied by X-ray diffraction to identify crystalline phases, and by Differential Scanning Calorimetry to follow the thermodynamic evolution of these forms versus temperature.
Results presented here show that, in addition to the already known conventional crystalline phase, whose nucleation domain extends between 233 K and 263 K and which melts at 349 K, racemic Ibuprofen can crystallize in another polymorphic phase. The nucleation of this new polymorphic variety is triggered by a stay at least 60 degrees below the glass transition temperature Tg of Ibuprofen (Tg = 228 K). This nucleation is probably of heterogeneous type. The new phase melts well below the conventional one, i.e. at 290 K. A schematic free energy diagram is provided allowing establishing the relative thermodynamic stability of the two polymorphs.
These results establish, for the first time, that Ibuprofen can exist under two different crystalline phases which constitute a monotropic system, the new form being metastable.
KEY WORDSglass transition ibuprofen nucleation polymorphism
This work is supported by the Hubert Curien partnership PESSOA grant. Region Nord/Pas de Calais and an INTERREG (FEDER) grant helped in providing X-ray equipment.
- 1.J. Bernstein. Polymorphism in molecular crystals. Oxford Science, Oxford, 2002.Google Scholar
- 5.A. H. Nada, S. M. Al-Saidan, and B. W. Mueller. Crystal modification for improving physical and chemical properties of ibuprofen. Pharm. Technol. 29:90–101 (2005). (Nov).Google Scholar
- 6.T. Lee, C. S. Kuo, and Y. H. Chen. Solubility, polymorphism, crystallinity, and crystal habit of acetaminophen and ibuprofen. Pharm. Technol. 30:72–92 (2006). (Oct.).Google Scholar
- 7.J. F. McConnell. 2-(4-Isobuthylphenyl) propionic acid. C13 H18 O2 ibuprofen or prufen. Cryst. Struct. Comm. 3:73–75 (1974).Google Scholar
- 12.A. R. Brás, M. Dionisio, and N. T. Correia. Molecular motions in amorphous pharmaceuticals. In Proceedings of IWCS 2007, AIP CP 982:91–97 (2008).Google Scholar
- 14.K. F. Kelton. Crystal nucleation in liquids and glasses. In H. Ehrenreich, and D. Turnbull (eds.), Solid State Physics, Academic, San Diego, 1991, pp. 75–177.Google Scholar
- 15.J. E. Shelby. Introduction to glassy science and applications. Royal Society of Chemistry, Cambridge, United Kingdom, 2002.Google Scholar
- 17.A. Guinier. X-ray crystallographic technology. Hilgerand Watts, Hilger Division, London, 1952.Google Scholar
- 18.A. Burger, and R. Ramberger. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. Mikrochimica Acta. II:259–271 (1971).Google Scholar
- 19.A. Burger, and R. Ramberger. On the polymorphism of pharmaceuticals and other molecular crystals. I. Applicability of thermodynamic rules. Mikrochimica Acta. II:273–316 (1971).Google Scholar